Fixed-Duration Therapy (FDT) in Multibacillary Leprosy; Efficacy and Complications

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 2, 1996, Pages 123-127

  Vijayakumaran, Palanisamy ^a   Jesudasan, Kumar ^a   Manimozhi, Natarajan ^a  

^a Br of Epidemiol and Leprosy Contr   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ARTICLE; BACTERICIDAL ACTIVITY; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; WORLD HEALTH ORGANIZATION;

DRUG THERAPY, COMBINATION; HUMANS; LEPROSTATIC AGENTS; LEPROSY; TIME FACTORS;

EID: 0030017365     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ALMEIDA, J. G., CHRISTIAN, M. and Chacko, C. J. G. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India. Int. J. Lepr. 51 (1983) 382-384.
2. ALMEIDA, J. G., JESUDASAN, K., CHRISTIAN, M. and CHACKO, C. J. G. Relapse rates in lepromatous leprosy according to treatment regularity. Int. J. Lepr. 54 (1986) 16-20.
3. BECX-BLEUMINK, M. and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int. J. Lepr. 60 (1992) 173-184.
4. CHOPRA, N. K., AGARWAL, J. S. and PANDYA, P. G. Impact of multidrug therapy on leprosy in Baroda district (Gujarat). Indian J. Lepr. 61 (1989) 179-189.
5. GANAPATHI, R., PAI, R., GANDEWAR, K. L. and THRESSIA, X. J. For how long should a multibacillary leprosy patient be treated? Indian J. Lepr. 61 (1989) 467-471.
6. KATOCH, K., NATARAJAN, M., BAGGA, A. and KATOCH, V. M. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT. Int. J. Lepr. 59 (1991) 248-254.
7. LEPROSY UNIT, WHO, DIVISION OF CONTROL OF TROPICAL DISEASES. Risk of relapse in leprosy. Geneva: World Health Organization, 1994. WHO/ CTD/94.1.
8. MARCHOUX CHEMOTHERAPY STUDY GROUP. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Int. J, Lepr. 60 (1992) 525-535.
9. NOORDEEN, S. K. Relapse in lepromatous leprosy. Lepr. Rev. 42 (1971) 43-48.
10. PANNIKAR, V., JESUDASAN, K., VIJAYAKUMARAN, P. and CHRISTIAN, M. Relapse or late reversal reaction? Int. J. Lepr. 57 (1989) 526-528.
11. PATTYN, S. R., EYCKMANS, L. and GIGASE, P. Late reversal reaction after combined treatment of a patient with multibacillary leprosy. Ann. Soc. Belg. Med. Trop. 64 (1984) 291-294.
12. RAMESH, V., MISRA, R. S. and SAXENA, U. Multidrug therapy in multibacillary leprosy; experience in an urban leprosy center. Int. J. Lepr. 60 (1992) 13-17.
13. SUSMAN, I. A. Clinical observations on erythema nodosum leprosum (ENL). Lepr. Rev. 29 (1958) 227-231.
14. VAN BRAKEL, W., KIST, P., NOBLE, S. and O'TOOLE, L. Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in west Nepal. Lepr. Rev. 60 (1989) 45-50.
15. VAN DIEPEN, T. W. and MENGISTU, G. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. Int. J. Lepr. 53 (1985) 189-197.
16. VIJAYAKUMARAN, P., MANIMOZHI, N. and JESUDASAN, K. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Int. J. Lepr. 63 (1995) 18-22.
17. WATERS, M. F. R. Relapse following various types of multidrug therapy in multibacillary leprosy. (Editorial) Lepr. Rev. 66 (1995) 1-9.
18. WATERS, M. F. R., REES, R. J. W., LIANG, A. B. G., KHOO, K. F., MEADE, T. W., PARIKSHAK, N. and NORTH, W. R. S. The rate or relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Lepr. Rev. 57 (1986) 101-109.
19. WHO STUDY GROUP. Chemotherapy of leprosy for control programmes. Geneva: World Health Organization, 1982. Tech. Rep. Ser. 675.
20. WHO STUDY GROUP. Chemotherapy of leprosy. Geneva: World Health Organization, 1994, pp. 5-7. Tech. Rep. Ser. 847.